{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:44:27Z","timestamp":1788374667670,"version":"build-2803163510"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Adrenal tumors are mostly encountered as incidentalomas in patients undergoing imaging not performed for suspected adrenal disease; although the majority are benign and nonfunctioning, malignant tumors and functioning tumors need to be excluded. The purpose of this review is to highlight recent advances in the evaluation of adrenal tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>As a consequence of increased use of technologically improved imaging techniques, the detection of adrenal incidentalomas has continued to increase. The vast majority of adrenal tumors are adrenocortical adenomas. To discriminate malignant from benign tumors and to identify clinically relevant functioning tumors, necessitating therapeutic intervention, adrenal tumors are best evaluated with unenhanced computed tomography (CT) attenuation and 1\u200amg dexamethasone overnight suppression test. An unenhanced CT attenuation value of 10 Hounsfield units or less excludes adrenocortical carcinoma and pheochromocytoma. Testing for hyperaldosteronism should be performed in hypertensive and\/or hypokalemic patients, sex hormones, and steroid precursors in patients with clinical features suggestive of adrenocortical carcinoma. In patients with active extraadrenal malignancy and a single adrenal lesion without suspicion for metastasis elsewhere, CT-guided biopsy can be considered to rule out metastatic disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>All patients with an adrenal tumor and without a prior history of cancer should be initially evaluated by unenhanced CT attenuation and 1\u200amg overnight dexamethasone suppression test, and additional hormone testing when indicated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cco.0000000000000528","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T04:20:43Z","timestamp":1552450843000},"page":"243-246","source":"Crossref","is-referenced-by-count":27,"title":["Screening in adrenal tumors"],"prefix":"10.1097","volume":"31","author":[{"given":"Eleonora P.M.","family":"Corssmit","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology"},{"name":"Center of Endocrine Tumors Leiden (CETL), Department of Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M.","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology"},{"name":"Center of Endocrine Tumors Leiden (CETL), Department of Endocrinology"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/jpsu.2001.22280","article-title":"Adrenocortical tumors in children","volume":"36","author":"Ciftci","year":"2001","journal-title":"J Pediatr Surg"},{"key":"R2-20230901","first-page":"637644","article-title":"Study group on Adrenal Tumors of the Italian Society of Endocrinology. A survey on adrenal incidentaloma in Italy","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20230901","first-page":"851","article-title":"AME position statement on adrenal incidentaloma","volume":"163","author":"Terzolo","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"R4-20230901","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R6-20230901","article-title":"A multimodality review of adrenal tumors","author":"Bhargava","year":"2018","journal-title":"Curr Probl Diagn Radiol"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.13448","article-title":"Diagnostic performance of unenhanced computed tomography and 18 F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1210\/jc.2017-00254","article-title":"Performance of 18F-FDG PET\/CT in the characterization of adrenal masses in noncancer patients: a prospective study","volume":"102","author":"Guerin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamcollsurg.2005.11.005","article-title":"Assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?","volume":"202","author":"Sturgeon","year":"2006","journal-title":"J Am Coll Surg"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mayocpiqo.2017.11.002","article-title":"Clinical, biochemical, and radiological characteristics of s single-center retrospective cohort of 705 large adrenal tumors","volume":"2","author":"Iniguez-Ariza","year":"2018","journal-title":"Mayo Clinic Proc Innov Qual Outcomes"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-16-0297","article-title":"Diagnosis of endocrine disease: the diagnostic performance of adrenal biopsy: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"Clin Endocrinol Metab"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-17-0990","article-title":"Management of endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited","volume":"179","author":"Williams","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"SPARTACUS Investigators. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/jc.2018-01532","article-title":"CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma","volume":"104","author":"Canu","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker for detecting malignancy in adrenal tumors","volume":"97","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1158\/1078-0432.CCR-16-3156","article-title":"Unique and novel urinary metabolomic features in malignant versus benign adrenal neoplasms","volume":"23","author":"Patel","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001622-201905000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:57:23Z","timestamp":1693551443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201905000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000528","relation":{},"ISSN":["1040-8746","1531-703X"],"issn-type":[{"value":"1040-8746","type":"print"},{"value":"1531-703X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}